Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
出版年份 2017 全文链接
标题
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume 15, Issue 7, Pages 677-688
出版商
Informa UK Limited
发表日期
2017-06-02
DOI
10.1080/14787210.2017.1338139
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
- (2017) Vincent H. Tam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients
- (2016) Francesca Mattioli et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements
- (2016) Marta Ulldemolins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients
- (2016) Sumith K. Mathew et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock
- (2015) K. Tamme et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock: Does Standard Dosing Result in Therapeutic Plasma Concentrations?
- (2015) Kristina Öbrink-Hansen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adequacy of High-Dose Cefepime Regimen in Febrile Neutropenic Patients with Hematological Malignancies
- (2015) Fekade Bruck Sime et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival
- (2015) Nathaniel J. Rhodes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
- (2015) Sutep Jaruratanasirikul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
- (2015) Marta Ulldemolins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
- (2015) Manjunath P. Pai et al. CLINICAL PHARMACOKINETICS
- Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapy
- (2015) Mieke Carlier et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
- (2015) Samuel L. Aitken et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial
- (2015) Fekade Bruck Sime et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
- (2015) Mohd H. Abdul-Aziz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis
- (2015) Shinji Kawano et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Pharmacokinetics of an Extended 4-hour Infusion of Piperacillin-Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
- (2015) Don-Kelena Awissi et al. PHARMACOTHERAPY
- How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
- (2014) Gloria Wong et al. BMC INFECTIOUS DISEASES
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course
- (2014) Mieke Carlier et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dosing regimen of meropenem for adults with severe burns: a population pharmacokinetic study with Monte Carlo simulations
- (2014) A. Ramon-Lopez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
- (2014) J. M. Varghese et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
- (2014) G. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study
- (2014) Frédéric Frippiat et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients
- (2014) Kevin S. Akers et al. Journal of Trauma and Acute Care Surgery
- Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
- (2013) Gloria Wong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia
- (2013) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
- (2013) E. Asin-Prieto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations
- (2013) J. M. Butterfield et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit
- (2013) S. Christian Cheatham et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Analysis of Piperacillin Administered with Tazobactam in Critically Ill, Morbidly Obese Surgical Patients
- (2013) Ashley W. Sturm et al. PHARMACOTHERAPY
- Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections
- (2012) T. W. Felton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
- (2012) Mahipal G Sinnollareddy et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin
- (2012) Isabelle K. Delattre et al. CLINICAL BIOCHEMISTRY
- β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia
- (2012) Yoshiro Hayashi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
- (2012) A. E. Muller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Protein Binding: Do We Ever Learn?
- (2011) Markus A. Zeitlinger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations
- (2011) Bernard Georges et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia
- (2011) Sutep Jaruratanasirikul et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
- (2010) I. Bilgrami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of meropenem dosage in the critically ill population based on renal function
- (2010) Jared L. Crandon et al. INTENSIVE CARE MEDICINE
- In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy
- (2010) Mickaël Riou et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
- (2010) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients
- (2010) S. Christian Cheatham et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Population pharmacokinetics of meropenem in burn patients
- (2010) K. Doh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative Pharmacodynamics of Intermittent and Prolonged Infusions of Piperacillin/Tazobactam Using Monte Carlo Simulations and Steady-State Pharmacokinetic Data from Hospitalized Patients
- (2009) Katherine M Shea et al. ANNALS OF PHARMACOTHERAPY
- Population Pharmacokinetics of Ceftazidime in Intensive Care Unit Patients: Influence of Glomerular Filtration Rate, Mechanical Ventilation, and Reason for Admission
- (2009) B. Georges et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
- (2009) J. L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
- (2009) Arantxazu Isla et al. CLINICAL PHARMACOKINETICS
- Antibiotic resistance—What’s dosing got to do with it?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
- (2009) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
- (2008) Peggy S. McKinnon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now